Concepedia

Richard Hjorth

RH

5

Publications

240

Citations

5

H-Index

1997

Active since

Affiliations

Program for Appropriate Technology in Health(Current)

Icahn School of Medicine at Mount Sinai

Mahidol Oxford Tropical Medicine Research Unit

Mahidol University

Institute of Vaccine and Medical Biologicals

Richard Hjorth is an author at Program for Appropriate Technology in Health specializing in influenza vaccines, vaccination, and vaccine development.

Top concepts

Publications per year

1997–2022

5

Publications

5

A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses

Weina Sun, Yonghong Liu, Fatima Amanat et al. · Nature Communications · 2021 · 116 citations · Full text

Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial

Punnee Pitisuttithum, Viravarn Luvira, Saranath Lawpoolsri et al. · EClinicalMedicine · 2022 · 54 citations · Full text

Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam

Anh Duc Dang, Vũ Đình Thiểm, Ha Hai Vu et al. · Vaccine · 2022 · 39 citations · Full text

Stabilizing cold-adapted influenza virus vaccine under various storage conditions

Dean A. Yannarell, Kenneth M. Goldberg, Richard Hjorth · Journal of Virological Methods · 2002 · 19 citations

, , +4

The effect of Syntex adjuvant formulation (SAF-m) on humoral immunity to the influenza virus in the mouse

Richard Hjorth, Geraldine M. Bonde, Elizabeth D. Piner et al. · Vaccine · 1997 · 12 citations

, , +11

Rows per page

1–5 of 5